SCHEMBL29689331

CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)CN)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	NPR1	P16066	1/20	0.77

▸	NPR3	P17342	1/20	0.77

▸	RXFP4	Q8TDU9	5/20	0.62

▸	RXFP3	Q9NSD7	5/20	0.62

▸	MC4R	P32245	2/20	0.59

▸	MC1R	Q01726	2/20	0.59

▸	INSR	P06213	1/20	0.59

▸	F11	P03951	2/20	0.59

▸	KLK7	P49862	2/20	0.58

▸	CSNK2A2	P19784	1/20	0.56

▸	CSNK2B	P67870	1/20	0.56

▸	CSNK2A1	P68400	1/20	0.56

▸	CSNK2A3	Q8NEV1	1/20	0.56

▸	KCNMA1	Q12791	1/20	0.56

▸	KCNMB4	Q86W47	1/20	0.56

▸	TNFSF11	O14788	1/20	0.55

▸	MC3R	P41968	1/20	0.55

▸	KRAS	P01116	1/20	0.54

▸	CXCR4	P61073	1/20	0.54

▸	KCNA3	P22001	1/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29376235	0.93	NPR1 (0.88)	NPR1NPR3RXFP4RXFP3MC4R
Ularitide SCHEMBL27908491	0.92	NPR1 (0.79)	NPR1NPR3RXFP4RXFP3MC4R
Ularitide SCHEMBL29484210	0.92	NPR1 (0.79)	NPR1NPR3RXFP4RXFP3MC4R
SCHEMBL29711548	0.91	NPR1 (0.86)	NPR1NPR3RXFP4RXFP3MC4R
Hydrochloric Acid SCHEMBL29495482	0.91	NPR1 (0.85)	NPR1NPR3RXFP4RXFP3MC4R
Carperitide SCHEMBL218549	0.90	NPR1 (0.94)	NPR1NPR3RXFP4RXFP3MC4R
SCHEMBL31332082	0.88	NPR1 (0.78)	NPR1NPR3MC4RMC1RF11
Acetic Acid SCHEMBL29363649	0.88	NPR1 (0.87)	NPR1NPR3MC4RMC1RINSR
Ularitide SCHEMBL29357163	0.86	NPR1 (0.71)	NPR1NPR3RXFP4RXFP3MC4R
SCHEMBL29379928	0.82	NPR1 (0.78)	NPR1NPR3MC4RMC1RINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	LONGEVITY BIOTECH, INC.	2024-11-14	—	—	US	disclosed
US-20240108627-A1	Phosphodiesterase Inhibitor Treatment	CYRANO THERAPEUTICS, INC.	2024-04-04	—	—	US	disclosed
US-20220226332-A1	Phosphodiesterase Inhibitor Treatment	CYRANO THERAPEUTICS, INC.	2022-07-21	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	SCTR, GIPR, APLNR	NPR1 21/4885NPR3 39/4885RXFP4 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.